JB Chemicals & Pharmaceuticals has informed that the Company has opted to submit to the Exchange standalone financial results during the financial year 2018-19. Accordingly, the Company shall submit standalone financial results as contemplated in Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.